Matrix metalloproteinases and their inhibitors in acute myeloid leukemia.
Ismair
M G
MG
Institute of Clinical Hematology, GSF Forschungszentrum für Umwelt und Gesundheit, Munich, Germany.
Ries
C
C
Petrides
P E
PE
D000208:Acute Disease; D000906:Antibodies; D017364:Collagenases / Q000096:biosynthesis* / Q000737:chemistry / Q000302:isolation & purification; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006023:Glycoproteins / Q000096:biosynthesis* / Q000302:isolation & purification; D006801:Humans; D007951:Leukemia, Myeloid / Q000201:enzymology*; D020780:Matrix Metalloproteinase 9; D061965:Matrix Metalloproteinase Inhibitors; D011480:Protease Inhibitors; D019714:Tissue Inhibitor of Metalloproteinases; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D000906:Antibodies; D006023:Glycoproteins; D061965:Matrix Metalloproteinase Inhibitors; D011480:Protease Inhibitors; D019714:Tissue Inhibitor of Metalloproteinases; D014409:Tumor Necrosis Factor-alpha; D017364:Collagenases; D020780:Matrix Metalloproteinase 9